Target intelligence / Profile preview

Thioredoxin domain-containing protein 12 (TXNDC12)

Target
TXNDC12
Molecular classification
Enzyme, Protein disulfide isomerase family, Thioredoxin superfamily, Endoplasmic reticulum protein
01

Overview

Thioredoxin domain-containing protein 12 (TXNDC12) is an enzyme of the thioredoxin superfamily localized in the endoplasmic reticulum, functioning primarily as a protein-disulfide isomerase[1][5]. It catalyzes the formation and rearrangement of disulfide bonds during protein folding, contributing to the proper maturation of secretory and membrane proteins, and plays a protective role against endoplasmic reticulum stress[1][5]. TXNDC12 is upregulated in multiple cancers, including hepatocellular carcinoma and glioma, where it promotes tumor metastasis and epithelial–mesenchymal transition (EMT) through activation and nuclear translocation of β-catenin and upregulation of ZEB1[1][3]. Its high expression correlates with poor clinical outcomes and increased tumor aggressiveness, supporting its potential as a therapeutic target and prognostic biomarker in cancer[1][3].

Other names
Thioredoxin domain-containing protein 12TLP19ER protein 18ERp18ER protein 19ERp19ERP16ERP18ERP19hAG-1AGR1PDIA16Endoplasmic reticulum resident protein 18Endoplasmic reticulum resident protein 19Thioredoxin-like protein p19hTLP19anterior gradient homolog 1AG1TXD12_HUMANHTLP19HAG-1
02

Biological functions

Protein disulfide isomerizationNative disulfide bond formationProtein folding in the endoplasmic reticulumCellular response to endoplasmic reticulum stressRegulation of epithelial–mesenchymal transition (EMT)
03

Disease associations

Cancer (notably hepatocellular carcinoma and glioma)Tumor metastasisPrognostic marker for glioma
04

Biomarkers

Overexpression indicates poor prognosis in hepatocellular carcinomaHigh expression associated with aggressive features and poor outcome in gliomasPrognostic biomarker in gliomas when combined with IDH and 1p/19q status

Beyond the preview

Go deeper on Thioredoxin domain-containing protein 12 (TXNDC12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thioredoxin domain-containing protein 12 (TXNDC12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call